3809

543298

VINEETLAB

img img img img
No Data Available

VINEET LABORATORIES LTD Share Price Update

As of the latest trading session, VINEET LABORATORIES LTD is trading at ₹34, down by ₹-1.00 or -2.85% from its previous close. The stock has moved between ₹33.81 and ₹35.00 today. Over the past year, the stock has delivered a return of 28.58%. In the last month, it has returned -8.06%.

VINEET LABORATORIES LTD performance

Today’s low Today’s high
₹ 33.81 ₹ 35.00
₹ 33.97
52 week low 52 week high
₹ 24.01 ₹ 43.50
₹ 33.97
Open Price ₹ 35.00
Prev. Close ₹ 35.00
Volume (Shares) 31392.00
Total traded value ₹ 10.66
Upper Circuit ₹ 36.75
Lower Circuit ₹ 33.25
info

Investment Returns

Over 1 Month -8.06% Over 3 Months 18.52% Over 6 Months 0.00% Over 1 Year 28.58%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VINEET LABORATORIES LTD fundamentals


  • Market cap (Cr) 65.20
  • P/E Ratio (TTM) -6.63
  • Beta 0.59
  • Book Value / share 23.00
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.85
info icon alternate text
  • Market cap (Cr) 65.30
  • P/E Ratio (TTM) -6.63
  • Beta 0.62
  • Book Value / share 23.00
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.85
info icon alternate text

VINEET LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 15.65
Operating Expense 14.87
Net Profit 0.85
Net Profit Margin (%) 5.43
Earnings Per Share (EPS) 0.92
EBITDA 2.54
Effective Tax Rate (%) -3.65
Particulars SEP 2025 (Values in Cr)
Revenue 17.42
Operating Expense 17.06
Net Profit 0.40
Net Profit Margin (%) 2.29
Earnings Per Share (EPS) 0.43
EBITDA 3.19
Effective Tax Rate (%) -8.10
Particulars JUN 2025 (Values in Cr)
Revenue 7.44
Operating Expense 8.36
Net Profit -0.87
Net Profit Margin (%) -11.69
Earnings Per Share (EPS) -0.94
EBITDA 0.33
Effective Tax Rate (%) 4.44
Particulars MAR 2025 (Values in Cr)
Revenue 14.08
Operating Expense 26.68
Net Profit -10.53
Net Profit Margin (%) -74.78
Earnings Per Share (EPS) -11.42
EBITDA -9.66
Effective Tax Rate (%) 6.23
Particulars DEC 2024 (Values in Cr)
Revenue 18.10
Operating Expense 23.80
Net Profit -5.71
Net Profit Margin (%) -31.54
Earnings Per Share (EPS) -6.19
EBITDA -4.10
Effective Tax Rate (%) -0.52
Particulars MAR 2025 (Values in Cr)
Revenue 75.00
Operating Expense 97.76
Net Profit -20.19
Net Profit Margin (%) -26.91
Earnings Per Share (EPS) -21.90
EBITDA -14.30
Effective Tax Rate (%) 2.79
Particulars MAR 2024 (Values in Cr)
Revenue 150.59
Operating Expense 150.69
Net Profit 1.03
Net Profit Margin (%) 0.68
Earnings Per Share (EPS) 1.11
EBITDA 7.66
Effective Tax Rate (%) -183.33
Particulars MAR 2023 (Values in Cr)
Revenue 212.29
Operating Expense 210.39
Net Profit 1.25
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 1.36
EBITDA 7.78
Effective Tax Rate (%) 38.42
Particulars MAR 2022 (Values in Cr)
Revenue 191.17
Operating Expense 182.12
Net Profit 6.64
Net Profit Margin (%) 3.47
Earnings Per Share (EPS) 7.16
EBITDA 13.45
Effective Tax Rate (%) 28.98
Particulars MAR 2021 (Values in Cr)
Revenue 243.48
Operating Expense 239.80
Net Profit 1.78
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 2.18
EBITDA 8.54
Effective Tax Rate (%) 56.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.71
EBITDA Margin -19.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.67
ROE % 2.31
ROCE % 6.59
Total Debt to Total Equity 1.10
EBITDA Margin 4.85
Particulars MAR 2023 (Values in Cr)
Book Value / Share 36.54
ROE % 3.74
ROCE % 8.51
Total Debt to Total Equity 0.86
EBITDA Margin 3.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 36.03
ROE % 22.19
ROCE % 22.35
Total Debt to Total Equity 0.65
EBITDA Margin 7.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 28.87
ROE % 13.18
ROCE % 32.64
Total Debt to Total Equity 0.46
EBITDA Margin 3.51
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.66
Total Assets 94.54
Total Liabilities 94.54
Total Equity 14.64
Share Outstanding 0
Price to Book Ratio 1.92
Return on Assets (%) -21.35
Return on Capital (%) -36.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 116.87
Total Liabilities 116.87
Total Equity 34.72
Share Outstanding 0
Price to Book Ratio 1.31
Return on Assets (%) 0.87
Return on Capital (%) 1.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.94
Total Assets 115.84
Total Liabilities 115.84
Total Equity 33.68
Share Outstanding 0
Price to Book Ratio 1.12
Return on Assets (%) 1.08
Return on Capital (%) 1.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.11
Total Assets 133.31
Total Liabilities 133.31
Total Equity 33.21
Share Outstanding 0
Price to Book Ratio 1.32
Return on Assets (%) 4.97
Return on Capital (%) 11.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.10
Total Assets 108.74
Total Liabilities 108.74
Total Equity 26.61
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.63
Return on Capital (%) 4.55
Particulars MAR 2025 (Values in Cr)
Net Income -20.77
Cash from Operations 11.61
Cash from Investing -3.18
Cash from Financing -8.23
Net change in Cash 0.07
Free Cash Flow 12.65
Particulars MAR 2024 (Values in Cr)
Net Income 0.36
Cash from Operations -6.35
Cash from Investing -2.22
Cash from Financing 8.42
Net change in Cash -0.40
Free Cash Flow -3.56
Particulars MAR 2023 (Values in Cr)
Net Income 2.02
Cash from Operations -6.62
Cash from Investing -6.68
Cash from Financing 0.27
Net change in Cash -16.02
Free Cash Flow 1.00
Particulars MAR 2022 (Values in Cr)
Net Income 9.34
Cash from Operations 10.81
Cash from Investing -3.67
Cash from Financing 11.95
Net change in Cash 15.90
Free Cash Flow 10.81
Particulars MAR 2021 (Values in Cr)
Net Income 4.05
Cash from Operations 26.63
Cash from Investing -7.80
Cash from Financing 18.61
Net change in Cash 38.29
Free Cash Flow 26.63
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2301.05 38.19 17.19 38981.18 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA IND LT 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

VINEET LABORATORIES LTD shareholding pattern

Holding
93.65%
5.98%
0.35%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VINEET LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
33.97 -2.94 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 35.10
  • 26 Days 35.50
  • 10 Days 35.30
  • 50 Days 34.80
  • 12 Days 35.40
  • 100 Days 34.00
  • 20 Days 35.60
  • 200 Days 33.90
34.80 PIVOT
First Support 34.50 First Resistance 35.30 Second Support 34.00 Second Resistance 35.60 Third Support 33.70 Third Resistance 36.10
RSI 48.28 ADX 12.57 MACD -0.08 Williams % R -72.78 Commodity Channel Index (CCI) -62.33
Date 2025-05-12 Week 23220.00 Same Day 9828.00 Month 20952.00
1 Year 0.60 3 Year 0.92
Over 1 Month
-8.06% down
Over 1 Year
28.58% down
Over 3 Months
18.52% down
Over 3 Years
-3.91% down
Over 6 Months
0.00% down
Over 5 Years
-2.13% down

VINEET LABORATORIES LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2022 1.0 Final 20 Sep 2022 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2022 1.0 Final 20 Sep 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vineet Laboratories Ltd?

Answer Field

Vineet Laboratories Ltd share price is for NSE ₹ 34.00 & for BSE ₹ 34.00 as on May 29 2026 03:29 PM.

What is the Market Cap of Vineet Laboratories Ltd Share?

Answer Field

The market cap of Vineet Laboratories Ltd for NSE ₹ 65.20 & for BSE ₹ 0.00 as on May 29 2026 03:29 PM.

What is the 52 Week High and Low of Vineet Laboratories Ltd?

Answer Field

The 52 Week High and Low of Vineet Laboratories Ltd for NSE is ₹ 43.50 and ₹ 24.01 and for BSE is ₹ 43.56 and ₹ 23.82.

What is 1 year return for Vineet Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 28.58%.

What is the P/E Ratio of Vineet Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:29 PM the price-to-earnings (PE) ratio for Vineet Laboratories Ltd share is -6.63.

What is the PB ratio of Vineet Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:29 PM, the price-to-book (PB) ratio for Vineet Laboratories Ltd share is 23.00.

How to Buy Vineet Laboratories Ltd Share?

Answer Field

You can trade in Vineet Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vineet Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Vineet Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vineet Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|